PILAR GARIN-CHESA

Person

BIBERACH/RISS, DE

People

Patents Grantslast 30 patents

Information Patent Grant
FAP-activated anti-tumour compounds
- Patent number 6,613,879
- Issue date Sep 2, 2003
- Boehringer Ingelheim Pharma KG
- Raymond A. Firestone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant human anti-Lewis Y antibodies
- Patent number 6,518,415
- Issue date Feb 11, 2003
- Ludwig Institute for Cancer Research
- Kathryn Lesley Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FAPα-specific antibody with improved producibility
- Patent number 6,455,677
- Issue date Sep 24, 2002
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating cancers which present antigen FB5 with humanize...
- Patent number 6,391,302
- Issue date May 21, 2002
- Ludwig Institute for Cancer Research
- Thomas Paul Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating cancers
- Patent number 6,348,195
- Issue date Feb 19, 2002
- Memorial Sloan Kettering Cancer Center
- Thomas Paul Wallace
- G01 - MEASURING TESTING
Information Patent Grant
Recombinant human anti-Lewis Y antibodies
- Patent number 6,310,185
- Issue date Oct 30, 2001
- Memorial Sloan Kettering Cancer Center
- Thomas P. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for detecting cancer cells by using humanized antibodies wh...
- Patent number 6,217,868
- Issue date Apr 17, 2001
- Ludwig Institute for Cancer Research
- Thomas Paul Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for detecting cancers
- Patent number 6,124,106
- Issue date Sep 26, 2000
- Ludwig Institute for Cancer Research
- Thomas Paul Wallace
- G01 - MEASURING TESTING
Information Patent Grant
Recombinant human anti-FB5 antibodies
- Patent number 6,090,930
- Issue date Jul 18, 2000
- Ludwig Institute for Cancer Research
- Thomas Paul Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant human anti-LK26 antibodies
- Patent number 5,952,484
- Issue date Sep 14, 1999
- Sloan-Kettering Cancer Center
- Thomas Paul Wallace
- G01 - MEASURING TESTING
Information Patent Grant
Recombinant human anti-Lewis Y antibodies
- Patent number 5,874,060
- Issue date Feb 23, 1999
- Memorial Sloan Kettering Cancer Center
- Kathryn Lesley Armour
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor rejection antigen precursor
- Patent number 5,843,448
- Issue date Dec 1, 1998
- Ludwig Institute of Cancer Research
- Yao-Tseng Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant humanized anti-FB5 antibodies
- Patent number 5,811,522
- Issue date Sep 22, 1998
- Ludwig Institute for Cancer Research
- Thomas Paul Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant human anti-LK26 antibodies
- Patent number 5,646,253
- Issue date Jul 8, 1997
- Memorial Sloan Kettering Cancer Center
- Thomas Paul Wallace
- G01 - MEASURING TESTING
Information Patent Grant
Isolated antigen endo glyx-1
- Patent number 5,618,534
- Issue date Apr 8, 1997
- Memorial Sloan Kettering Cancer Center
- Maria P. Sanz-Moncasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecule coding for fibroblast activation pro...
- Patent number 5,587,299
- Issue date Dec 24, 1996
- Memorial Sloan Kettering Cancer Center
- Wolfgang J. Rettig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies which bind to tumor rejection antigen precurs...
- Patent number 5,541,104
- Issue date Jul 30, 1996
- Ludwig Institute for Cancer Research
- Yao-Tseng Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody specific for vascular endothelial cell antigen...
- Patent number 5,536,641
- Issue date Jul 16, 1996
- Memorial Sloane Kittering Cancer Center
- Maria P. Sanz-Moncasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FAP-activated anti-tumor compounds
- Publication number 20030232742
- Publication date Dec 18, 2003
- Stefan Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAPalpha -specific antibody with improved producibility
- Publication number 20030143229
- Publication date Jul 31, 2003
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAP-activated anti-tumor compounds
- Publication number 20030055052
- Publication date Mar 20, 2003
- Stefan Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FAP-activated anti-tumor compounds
- Publication number 20020155565
- Publication date Oct 24, 2002
- Pilar Garin-Chesa
- B82 - NANO-TECHNOLOGY
Information Patent Application
Human FAP-alpha-specific antibodies
- Publication number 20020099180
- Publication date Jul 25, 2002
- Klaus Pfizenmaier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FAPALPHA-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
- Publication number 20020052480
- Publication date May 2, 2002
- JOHN EDWARD PARK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

PILAR GARIN-CHESA

Person

Patents Grantslast 30 patents

FAP-activated anti-tumour compounds

Recombinant human anti-Lewis Y antibodies

FAP&#x03B1;-specific antibody with improved producibility

Method for treating cancers which present antigen FB5 with humanize...

Method for treating cancers

Recombinant human anti-Lewis Y antibodies

Methods for detecting cancer cells by using humanized antibodies wh...

Method for detecting cancers

Recombinant human anti-FB5 antibodies

Recombinant human anti-LK26 antibodies

Recombinant human anti-Lewis Y antibodies

Tumor rejection antigen precursor

Recombinant humanized anti-FB5 antibodies

Recombinant human anti-LK26 antibodies

Isolated antigen endo glyx-1

Isolated nucleic acid molecule coding for fibroblast activation pro...

Monoclonal antibodies which bind to tumor rejection antigen precurs...

Monoclonal antibody specific for vascular endothelial cell antigen...

Patents Applicationslast 30 patents

FAP-activated anti-tumor compounds

FAPalpha -specific antibody with improved producibility

FAP-activated anti-tumor compounds

FAP-activated anti-tumor compounds

Human FAP-alpha-specific antibodies

FAPALPHA-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY

FAPα-specific antibody with improved producibility